NO760768L - - Google Patents
Info
- Publication number
- NO760768L NO760768L NO760768A NO760768A NO760768L NO 760768 L NO760768 L NO 760768L NO 760768 A NO760768 A NO 760768A NO 760768 A NO760768 A NO 760768A NO 760768 L NO760768 L NO 760768L
- Authority
- NO
- Norway
- Prior art keywords
- approx
- staphylococcus aureus
- suspension
- cells
- stained
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 94
- 241000191967 Staphylococcus aureus Species 0.000 claims description 75
- 238000003776 cleavage reaction Methods 0.000 claims description 62
- 230000007017 scission Effects 0.000 claims description 62
- 102000008946 Fibrinogen Human genes 0.000 claims description 51
- 108010049003 Fibrinogen Proteins 0.000 claims description 51
- 229940012952 fibrinogen Drugs 0.000 claims description 51
- 239000000872 buffer Substances 0.000 claims description 44
- 239000000725 suspension Substances 0.000 claims description 40
- 102000009123 Fibrin Human genes 0.000 claims description 29
- 108010073385 Fibrin Proteins 0.000 claims description 29
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 29
- 229950003499 fibrin Drugs 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 24
- 210000002966 serum Anatomy 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 21
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 17
- 238000011534 incubation Methods 0.000 claims description 14
- 235000015097 nutrients Nutrition 0.000 claims description 12
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 229920001451 polypropylene glycol Polymers 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 7
- 238000013207 serial dilution Methods 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- -1 polybutylene Polymers 0.000 claims description 4
- 229920001748 polybutylene Polymers 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- BEIHVSJTPTXQGB-QIXACUJNSA-N n'-anilino-n-phenyliminobenzenecarboximidamide Chemical compound C=1C=CC=CC=1N\N=C(C=1C=CC=CC=1)\N=NC1=CC=CC=C1 BEIHVSJTPTXQGB-QIXACUJNSA-N 0.000 claims description 3
- 150000004072 triols Chemical class 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims 3
- 238000011081 inoculation Methods 0.000 claims 2
- BRDIFBARJKLSSY-UHFFFAOYSA-N 2,3,4-triphenyl-2h-tetrazol-2-ium;chloride Chemical compound [Cl-].C1=[NH+]N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 BRDIFBARJKLSSY-UHFFFAOYSA-N 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 229920001281 polyalkylene Polymers 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 74
- 239000012153 distilled water Substances 0.000 description 15
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000002609 medium Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000004108 freeze drying Methods 0.000 description 6
- 108010065152 Coagulase Proteins 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000015271 coagulation Effects 0.000 description 5
- 238000005345 coagulation Methods 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000002518 antifoaming agent Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JEOLGCWRLRXABW-UHFFFAOYSA-N 2,5-diphenyl-2h-tetrazol-2-ium;chloride Chemical compound [Cl-].C1=CC=CC=C1C1=[NH+]N(C=2C=CC=CC=2)N=N1 JEOLGCWRLRXABW-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- JORABGDXCIBAFL-UHFFFAOYSA-M iodonitrotetrazolium chloride Chemical compound [Cl-].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C=CC=CC=2)=N1 JORABGDXCIBAFL-UHFFFAOYSA-M 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 239000006150 trypticase soy agar Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
- G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/882—Staphylococcus
- Y10S435/883—Staphylococcus aureus
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/556,504 US3990947A (en) | 1975-03-07 | 1975-03-07 | Composition for detecting fibrinogen, fibrinogen split products and fibrin split products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO760768L true NO760768L (he) | 1976-09-08 |
Family
ID=24221614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO760768A NO760768L (he) | 1975-03-07 | 1976-03-05 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3990947A (he) |
| JP (1) | JPS51117095A (he) |
| AU (1) | AU507738B2 (he) |
| BE (1) | BE839145A (he) |
| CA (1) | CA1061229A (he) |
| DE (1) | DE2608733A1 (he) |
| DK (1) | DK95676A (he) |
| FR (1) | FR2303291A1 (he) |
| GB (1) | GB1490466A (he) |
| IE (1) | IE42640B1 (he) |
| IT (1) | IT1057927B (he) |
| LU (1) | LU74498A1 (he) |
| NL (1) | NL7602094A (he) |
| NO (1) | NO760768L (he) |
| SE (1) | SE7602866L (he) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2525804B2 (de) * | 1975-06-10 | 1980-04-03 | Behringwerke Ag, 3550 Marburg | Stabiler Clumping-Faktor, Verwendung desselben zum Nachweis von Fibrinogen- und Fibrinspaltprodukten und Herstellung desselben |
| DE2644622C3 (de) * | 1976-10-02 | 1979-11-29 | Behringwerke Ag, 3550 Marburg | Extraktion von Mikroorganismen und diese enthaltende diagnostische Mittel |
| US4461830A (en) * | 1983-01-20 | 1984-07-24 | Buren Philpot V Jun | Serum fibrinogen viscosity in clinical medicine |
| US4567137A (en) * | 1983-01-20 | 1986-01-28 | Philpot Van B | Serum thrombin time in clinical medicine |
| US4873090A (en) * | 1985-03-27 | 1989-10-10 | Broncostat Pty. Limited | Non-adjuvenated vaccine |
| DD261844A1 (de) * | 1986-07-09 | 1988-11-09 | Adw Ddr | Verfahren zur praezipitation von fibrinmonomeren |
| IL80313A0 (en) * | 1986-09-19 | 1987-01-30 | Yissum Res Dev Co | Immunoassay reagents,kits and methods |
| US5424193A (en) * | 1993-02-25 | 1995-06-13 | Quidel Corporation | Assays employing dyed microorganism labels |
| CN110257475B (zh) * | 2019-06-28 | 2023-05-02 | 深圳市国赛生物技术有限公司 | 纤维蛋白原检测试剂及其制备方法及检测试剂制品 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3881993A (en) * | 1971-03-16 | 1975-05-06 | Miles Lab | Testing device for microorganisms |
| US3834991A (en) * | 1972-05-23 | 1974-09-10 | Warner Lambert Co | Colorimetric assay for lysozyme |
| US3790447A (en) * | 1972-07-05 | 1974-02-05 | Abbott Lab | Streptococci diagnostic method |
-
1975
- 1975-03-07 US US05/556,504 patent/US3990947A/en not_active Expired - Lifetime
-
1976
- 1976-02-17 GB GB6135/76A patent/GB1490466A/en not_active Expired
- 1976-02-19 IE IE323/76A patent/IE42640B1/en unknown
- 1976-02-27 SE SE7602866A patent/SE7602866L/xx not_active Application Discontinuation
- 1976-03-01 NL NL7602094A patent/NL7602094A/xx not_active Application Discontinuation
- 1976-03-02 FR FR7605819A patent/FR2303291A1/fr active Granted
- 1976-03-03 DE DE19762608733 patent/DE2608733A1/de not_active Withdrawn
- 1976-03-03 BE BE164818A patent/BE839145A/xx unknown
- 1976-03-03 IT IT48400/76A patent/IT1057927B/it active
- 1976-03-05 LU LU74498A patent/LU74498A1/xx unknown
- 1976-03-05 JP JP51024038A patent/JPS51117095A/ja active Granted
- 1976-03-05 DK DK95676*#A patent/DK95676A/da unknown
- 1976-03-05 CA CA247,241A patent/CA1061229A/en not_active Expired
- 1976-03-05 AU AU11727/76A patent/AU507738B2/en not_active Expired
- 1976-03-05 NO NO760768A patent/NO760768L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU74498A1 (he) | 1976-09-01 |
| BE839145A (fr) | 1976-07-01 |
| AU507738B2 (en) | 1980-02-28 |
| AU1172776A (en) | 1977-09-08 |
| IT1057927B (it) | 1982-03-30 |
| CA1061229A (en) | 1979-08-28 |
| IE42640B1 (en) | 1980-09-24 |
| JPS51117095A (en) | 1976-10-14 |
| US3990947A (en) | 1976-11-09 |
| DK95676A (da) | 1976-09-08 |
| IE42640L (en) | 1976-09-07 |
| FR2303291B1 (he) | 1980-08-01 |
| SE7602866L (sv) | 1976-09-08 |
| DE2608733A1 (de) | 1976-09-16 |
| NL7602094A (nl) | 1976-09-09 |
| GB1490466A (en) | 1977-11-02 |
| FR2303291A1 (fr) | 1976-10-01 |
| JPS5523080B2 (he) | 1980-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Avery et al. | Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III | |
| Stoenner et al. | Antigenic variation of Borrelia hermsii. | |
| US4029756A (en) | Serological procedure for determining presence of neisseria gonorrhoeae antibodies | |
| Thomas et al. | Quantitative endotoxin determination in blood with a chromogenic substrate | |
| US4038143A (en) | Test kit for the genetic detection of microorganisms | |
| US3930956A (en) | Method for the genetic detection of microorganisms | |
| Van Vuurde et al. | Comparison of immunofluorescence colony-staining in media, selective isolation on pectate medium, ELISA and immunofluorescence cell staining for detection of Erwinia carotovora subsp. atroseptica and E. chrysanthemi in cattle manure slurry | |
| Hugo et al. | A quantitative and qualitative study of the lipolytic activity of single strains of seven bacterial species | |
| NO760768L (he) | ||
| EP0005512B1 (en) | A serological method for determining the presence of neisseria gonorrhoeae antibodies in human serum, a species-specific heat stable antigen to be used in this method and a method for the preparation of that antigen | |
| JPS58126784A (ja) | リン病の診断テスト法、リン菌のテスト用株およびテストキツト | |
| WO2007139601A2 (en) | Phenotypic engineering of spore | |
| US4351761A (en) | Purified antigen to test for Neisseria gonorrhoeae antibodies | |
| Chapman et al. | The coagulation of plasma by staphylococci | |
| Yoshikawa et al. | Pleiotropic alteration of activities of several toxins and enzymes in mutants of Staphylococcus aureus | |
| Sperber | The identification of staphylococci in clinical and food microbiology laboratories | |
| US8969520B2 (en) | Reagent for assaying anti-treponema pallidum antibody | |
| EP0363105B1 (en) | Stabilized extraction composition containing a sulfhydryl-containing reducing agent and its use in chlamydial and gonococcal determination | |
| JP2003505024A (ja) | 微生物、細胞、および組織の貯蔵 | |
| Moody et al. | Detection of brucellae and their antibodies by fluorescent antibody and agglutination tests | |
| Ferrieri et al. | Localization and characterization of the hippuricase activity of group B streptococci | |
| US20200355588A1 (en) | Method of pretreating blood sample | |
| EP0363089A2 (en) | Use of a protease in the extraction of chlamydial, gonococcal and herpes antigens | |
| JP2022530652A (ja) | ヒト由来のサンプルにおける微生物増殖を決定するための迅速な方法 | |
| Omonigho et al. | Microbiological quality assessment of garri with reference to thermonuclease activity |